Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in CDXS — Codexis, Inc.

CIK 1390777 NEW YORK, NY
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$510,846
+$169,126 QoQ
Shares Held
226,039
+7.8% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. CDXS ranks #242 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in CDXS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $510,846 226,039
2026-03-31 $341,720 209,645
2025-12-31 $333,739 204,749
2025-09-30 $508,125 208,249
2025-06-30 $507,030 207,800
2025-03-31 $603,608 224,390
2024-12-31 $1,053,576 220,876
2024-09-30 $626,615 203,447
2024-06-30 $880,914 284,166
2024-03-31 $879,576 252,028
2023-12-31 $806,843 264,539
2023-09-30 $450,896 238,570
2023-06-30 $662,532 236,619
2023-03-31 $879,062 212,334
2022-12-31 $1,007,155 216,128
2022-09-30 $1,407,803 232,311
2022-06-30 $2,204,727 210,777
2022-03-31 $4,554,523 220,879
2021-12-31 $6,856,290 219,261
2021-09-30 $4,874,015 209,545
2021-06-30 $4,011,884 177,047
2021-03-31 $4,901,961 214,153
2020-12-31 $4,683,952 214,565
2020-09-30 $2,524,240 215,012
2020-06-30 $2,529,135 221,854
2020-03-31 $2,989,471 267,874